WO2006124556A3 - Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same - Google Patents

Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same Download PDF

Info

Publication number
WO2006124556A3
WO2006124556A3 PCT/US2006/018370 US2006018370W WO2006124556A3 WO 2006124556 A3 WO2006124556 A3 WO 2006124556A3 US 2006018370 W US2006018370 W US 2006018370W WO 2006124556 A3 WO2006124556 A3 WO 2006124556A3
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutical formulations
administering
methods
same
inhalable pharmaceutical
Prior art date
Application number
PCT/US2006/018370
Other languages
French (fr)
Other versions
WO2006124556A2 (en
Inventor
Trevor Charles Roche
Original Assignee
Glaxo Group Ltd
Smithkline Beecham Corp
Trevor Charles Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd, Smithkline Beecham Corp, Trevor Charles Roche filed Critical Glaxo Group Ltd
Publication of WO2006124556A2 publication Critical patent/WO2006124556A2/en
Publication of WO2006124556A3 publication Critical patent/WO2006124556A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)

Abstract

Pharmaceutical formulations suitable for inhalation comprise at least one pharmaceutically active medicament and lactose anhydrate.
PCT/US2006/018370 2005-05-13 2006-05-11 Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same WO2006124556A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68076705P 2005-05-13 2005-05-13
US60/680,767 2005-05-13

Publications (2)

Publication Number Publication Date
WO2006124556A2 WO2006124556A2 (en) 2006-11-23
WO2006124556A3 true WO2006124556A3 (en) 2007-05-18

Family

ID=37431888

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/018370 WO2006124556A2 (en) 2005-05-13 2006-05-11 Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same

Country Status (1)

Country Link
WO (1) WO2006124556A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2739352T3 (en) 2009-02-26 2020-01-30 Glaxo Group Ltd Pharmaceutical formulations comprising 4 - {(1R) -2 - [(6- {2 - [(2,6-dichlorobenzyl) oxy] ethoxy} hexyl) amino] -1-hydroxyethyl} -2- (hydroxymethyl) phenol
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
GB201305825D0 (en) 2013-03-28 2013-05-15 Vectura Ltd New use

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010041164A1 (en) * 1998-12-11 2001-11-15 Volcmar Verkerk Pharmaceutical preparation for inhalation of an opioid

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010041164A1 (en) * 1998-12-11 2001-11-15 Volcmar Verkerk Pharmaceutical preparation for inhalation of an opioid

Also Published As

Publication number Publication date
WO2006124556A2 (en) 2006-11-23

Similar Documents

Publication Publication Date Title
IL175032A0 (en) Inhalable pharmaceutical formulations employing lactose anhydrate nad methods of administering the same
WO2006017505A3 (en) Pharmaceutical formulations comprising pleconaril for the treatment of airway diseases
WO2006105401A3 (en) Medicaments and methods combining an anticholinergic, a corticosteroid, and a long acting beta agonist
ID29181A (en) COMBINATION OF FORMOTEROL AND TIOTROPIUM SALT
WO2007126964A3 (en) Kinase inhibitors
WO2008131056A3 (en) Sustained release monoeximic formulations of opioid and nonopioid analgesics
WO2005112633A3 (en) Compounds and compositions for delivering active agents
WO2006059108A3 (en) ANTI-IL-IRl SINGLE DOMAIN ANTIBODIES AND THERAPEUTIC USES
WO2007149406A8 (en) Modified coagulation factor ix polypeptides and use thereof for treatment
WO2007025005A3 (en) Sustained release formulations of nalbuphine
WO2006008639A8 (en) Combination treatment for non-hematologic malignancies using an anti-igf-1r antibody
WO2005117895A8 (en) Compositions comprising meloxicam
WO2006008173A3 (en) Pharmaceutical formulations for inhalation
ZA200704285B (en) Reverse micelles based on phytosterols and acyglycerols and therapeutic uses thereof
WO2005044186A3 (en) Inhalable pharmaceutical formulations employing desiccating agents and methods of administering the same
WO2008128191A3 (en) Oral cephalotaxine dosage forms
WO2008008882A3 (en) Glucocorticoid receptor modulator and methods of use
WO2007133796A3 (en) Methods and compositions for treatment of sleep apnea comprising administration of an endothelin antagonist
WO2006064228A3 (en) Thiazolopyramidine compounds for the modulation of chemokine receptor activity
WO2008004100A9 (en) Therapeutic compounds
WO2005120518A3 (en) Use of atp analogues for treatment of cardiovascular diseases
WO2006124556A3 (en) Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same
EP1741430A4 (en) Remedy for psychoneurotic diseases
WO2005102374A3 (en) Immunomodulation by a therapeutic medication intended for treatment of diabetes and prevention of autoimmune diabetes
WO2008032222A3 (en) Treatment of vertigo with acetyl-l-leucine

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 06759641

Country of ref document: EP

Kind code of ref document: A2